Cannabis reform is sweeping Europe, and tremendous business opportunities are being created in the process. Nowhere on the continent is that more evident than in Germany where an emerging medical cannabis industry is demonstrating to the rest of the continent how regulated cannabis can work. Peter Homberg, a partner at leading international law firm Denton’s, will provide insight into current trends in Germany’s medical cannabis industry, the price structure for medical cannabis products in Germany, and important industry trends.

Germany is home to one of the largest legal cannabis markets on earth. Germany’s industry is young, however, it is growing at a rapid pace. Attorney Kai Friedrich-Niermann, co-founder of the International Cannabis Bar Association and the German Patient Roundtable, will provide an update on current German cannabis policy, how the industry is dealing with the coronavirus pandemic, as well as discuss what chances Germany and the rest of Europe have to legalize cannabis for adult use in the near future.

4-time NBA champion John Salley is a true expert when it comes to adaptation. In addition to winning championships with multiple teams in multiple decades in the NBA, John Salley is also an actor, television host, an activist for several worthy causes, vegan, and cannabis entrepreneur. Salley will share his abundant wisdom regarding the creation of effective strategies in a constantly evolving industry.

National Cannabis Industry Association co-founder and executive director Aaron Smith will provide an overview of the cannabis industry’s efforts to reform cannabis laws in the U.S. and discuss the major hurdles and issues facing the emerging cannabis industry. Aaron Smith will also discuss the cannabis industry’s outlook in the age of the ongoing COVID-19 pandemic.

COVID-19 has drastically changed our day-to-day lives and will continue to affect the way we do business for years to come. While it has been a win for cannabis businesses to be considered “essential” during this time, sales have still declined in most markets. If your business is not currently profitable or on the fast track to profitability, you may be in trouble. Now is the time to focus on getting lean while nurturing your core business. Companies that have successfully adapted to changing consumer trends and demand are currently expanding their market share. Swift and deliberate actions are required to optimize your operation for the current climate. In this session, Nic Easley, CEO of 3C Consulting and CEO & Managing Director of Multiverse Capital, will provide hard-hitting action items for each type of cannabis business that will improve your operational efficiency and prepare you for rough times ahead.

Canada is home to one of the oldest and most-established cannabis communities on earth and is the only country where tourists can legally purchase adult-use cannabis. Cannabis reform champion and industry expert Jamie Shaw will discuss the current state of Canada’s cannabis regulations, how Covid has impacted Canada’s cannabis industry, and what to expect in the future for Canada’s emerging cannabis industry. Shaw is a true cannabis expert and you do not want to miss her insightful presentation.

Canada was the second country to legalize cannabis for adult use, and the first G-7 nation to do so. Canada was already home to a robust medical cannabis industry when adult-use legalization was implemented and fusing the two industry sectors has resulted in mixed results. The Granddaddy of Canadian cannabis policy reform, John W. Conroy QC of Conroy & Company will discuss what is working in Canada and what is not, along with recommendations for how to improve Canada’s current cannabis policy.

An often overlooked, yet extremely important aspect of the cannabis industry is intellectual property law. Cannabis companies need to protect their intellectual property, as well as mitigate any issues that may arise out of their use of intellectual property. David Branfman of Branfman Mayfield Bustarde Reichenthal LLP will provide an update regarding new cases and laws having to do with cannabis and IP law, the U.S. Patent & Trademark Office dealing with the flood of trademark applications for CBD products, and new challenges/opportunities popping up in the cannabis IP space.

COVID-19 has the potential to radically change the North American cannabis industry. Alan Brochstein, a leading cannabis investment expert who has been following the industry and the publicly traded companies since 2013, will discuss both the positive and negative impacts on the industry and will also explain how some companies are set to thrive while others will likely wither away.